This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Show more...
CEO
Dennis Carlo
Employees
11
Country
US
ISIN
US00547W2089
WKN
000A1XA2F
Listings
0 Comments
Share your thoughts
FAQ
What is Adamis Pharmaceuticals stock price today?▼
The current price of ADMP is $0.78 USD — it has increased by +0.86% in the past 24 hours. Watch Adamis Pharmaceuticals stock price performance more closely on the chart.
What is Adamis Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adamis Pharmaceuticals stocks are traded under the ticker ADMP.
What is Adamis Pharmaceuticals market cap?▼
Today Adamis Pharmaceuticals has the market capitalization of 7.25M
What is Adamis Pharmaceuticals revenue for the last year?▼
Adamis Pharmaceuticals revenue for the last year amounts to 6.91M USD.
What is Adamis Pharmaceuticals net income for the last year?▼
ADMP net income for the last year is -29.81M USD.
How many employees does Adamis Pharmaceuticals have?▼
As of April 01, 2026, the company has 11 employees.
In which sector is Adamis Pharmaceuticals located?▼
Adamis Pharmaceuticals operates in the Manufacturing sector.
When did Adamis Pharmaceuticals complete a stock split?▼
The last stock split for Adamis Pharmaceuticals was on May 22, 2023 with a ratio of 1:70.
Where is Adamis Pharmaceuticals headquartered?▼
Adamis Pharmaceuticals is headquartered in San Diego, US.